Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• The mammalian target of rapamycin (mTOR) pathway is a critical regulator of cellular functions, including growth, proliferation, and survival.
• Aberrant mTOR pathway activation is implicated in various cancers, including bladder cancer, where it is observed in approximately 70% of urothelial carcinomas.
• mTOR signaling is initiated by upstream activators like phosphatidylinositol 3 kinase (PI3K) and protein kinase B (AKT), leading to the formation of mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2).

Purpose of the Study:

• To review the functional significance of the mammalian target of rapamycin (mTOR) signaling pathway in urothelial carcinoma.
• To explore the potential impact of mTOR pathway dysregulation on future therapeutic strategies for bladder cancer.
• To highlight novel insights into the biology and targeting of urothelial carcinoma through understanding signaling convergence onto mTOR complexes.

Main Methods:

• This review synthesizes existing literature on mTOR pathway signaling in bladder cancer.
• It analyzes molecular alterations within the mTOR pathway in urothelial carcinoma.
• The review discusses the distinct roles and downstream targets of mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2).

Main Results:

• High mTOR activity is a common feature in urothelial carcinomas, indicating its significant role in bladder cancer progression.
• Despite extensive research into molecular alterations, mTOR-targeted therapies have not yet yielded substantial clinical benefits in urothelial carcinoma.
• Unique differences in the composition of mTORC1 and mTORC2 complexes lead to distinct cellular functions and targets.

Conclusions:

• The mammalian target of rapamycin (mTOR) pathway plays a pivotal role in the pathogenesis and progression of bladder cancer.
• Further research into signaling convergence onto mTOR complexes is essential for uncovering unique biological insights and improving therapeutic strategies.
• Understanding the intricacies of mTOR signaling in urothelial carcinoma holds promise for the development of more effective targeted treatments for this aggressive disease.